Institute for Integrative Systems Biology, I²SysBio (Universitat de València - CSIC), 46908, Paterna, Valencia, Spain.
Centro de Estudios del Cannabis, CECANN, Santiago, Chile.
Plant Sci. 2020 Sep;298:110571. doi: 10.1016/j.plantsci.2020.110571. Epub 2020 Jun 27.
Cannabis sativa is a source of food, fiber and specialized metabolites such as cannabinoids, with psychoactive and pharmacological effects. Due to its expanding and increasingly-accepted use in medicine, cannabis cultivation is acquiring more importance and less social stigma. Humans initiated different domestication episodes whose later spread gave rise to a plethora of landrace cultivars. At present, breeders cross germplasms from different gene pools depending on their specific use. The fiber (hemp) and drug (marijuana) types of C. sativa differ in their cannabinoid chemical composition phenotype (chemotype) and also in the accumulation of terpenoid compounds that constitute a strain's particular flavor and scent. Cannabinoids are isoprenylated polyketides among which cannabidiolic acid (CBDA) and (-)-trans-Δ⁹-tetrahydrocannabinol acid (THCA) have been well-documented for their many effects on humans. Here, we review the most studied specialized metabolic pathways in C. sativa, showing how terpenes and cannabinoids share both part of the isoprenoid pathway and the same biosynthetic compartmentalization (i.e. glandular trichomes of leaves and flowers). We enlist the several studies that have deciphered these pathways in this species including physical and genetic maps, QTL analyses and localization and enzymatic studies of cannabinoid and terpene synthases. In addition, new comparative modeling of cannabinoid synthases and phylogenetic trees are presented. We describe the genome sequencing initiatives of several accessions with the concomitant generation of next-generation genome maps and transcriptomic data. Very recently, proteomic characterizations and systems biology approaches such as those applying network theory or the integration of multi-omics data have increased the knowledge on gene function, enzyme diversity and metabolite content in C. sativa. In this revision we drift through the history, present and future of cannabis research and on how second- and third-generation sequencing technologies are bringing light to the field of cannabis specialized metabolism. We also discuss different biotechnological approaches for producing cannabinoids in engineered microorganisms.
大麻是一种食物、纤维和特殊代谢物(如大麻素)的来源,具有精神活性和药理作用。由于其在医学中的应用不断扩大和日益被接受,大麻种植获得了更多的重视,社会污名也越来越少。人类启动了不同的驯化事件,后来这些事件的传播导致了大量的地方品种。目前,种植者根据其特定用途交叉来自不同基因库的种质。纤维(大麻)和药物(大麻)类型的大麻在其大麻素化学组成表型(化学型)和萜烯化合物的积累上有所不同,萜烯化合物构成了一个菌株的特殊风味和气味。大麻素是异戊烯基聚酮化合物,其中大麻二酚酸(CBDA)和(-)-反式-Δ⁹-四氢大麻酸(THCA)因其对人类的许多影响而得到了很好的记录。在这里,我们回顾了在大麻中研究最多的特殊代谢途径,展示了萜烯和大麻素如何共享部分异戊烯途径和相同的生物合成区隔化(即叶和花的腺毛)。我们列出了在该物种中阐明这些途径的几项研究,包括物理和遗传图谱、QTL 分析以及大麻素和萜烯合酶的定位和酶学研究。此外,还提出了新的大麻素合酶比较建模和系统发育树。我们描述了几个品系的基因组测序计划,同时生成了下一代基因组图谱和转录组数据。最近,蛋白质组学特征和系统生物学方法,如应用网络理论或整合多组学数据的方法,增加了对大麻中基因功能、酶多样性和代谢物含量的了解。在本次修订中,我们回顾了大麻研究的历史、现状和未来,以及第二代和第三代测序技术如何为大麻特殊代谢领域带来曙光。我们还讨论了在工程微生物中生产大麻素的不同生物技术方法。